This is from PHOSPHAGENICS US-based commercialiazation partner Neura Therapeutik.
PAIN costs the US $635billion annually
Industry analysts estimate that more than 1.5 billion people around the world suffer from chronic pain, making it the number one reason patients seek medical care. In fact, studies have shown that pain leads to more than 50 million lost workdays each year. The cost of pain, including medical bills and lost workdays, is estimated at $100 billion per year. The US market for pain-management therapeutics is estimated to generate more than $40 billion annually and is predicted to grow to $60 billion by 2015. This market includes treatments for a wide range of conditions including postoperative pain, cancer pain, arthritis pain, migraine pain, neuropathic pain, and back pain.
Imagine the global market because make no doubt this will be a global product.
Make up for my loss from POH at the start of the year.
- Forums
- ASX - By Stock
- AVE
- success!
success! , page-38
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
63 | 101422109 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 20872825 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 100172109 | 0.002 |
23 | 71850508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 20872825 | 7 |
0.004 | 23380242 | 19 |
0.005 | 27709765 | 14 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |